Latest Articles

Publication Date
A Dual Approach Pyschotherapy Toolkit For Endometriosis Patients - Endometriosis Foundation of America

A Dual Approach Pyschotherapy Toolkit For Endometriosis Patients Endometriosis Foundation of America

Published: March 4, 2026, 1:07 p.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus

Published: Feb. 27, 2026, 7:22 a.m.
New climbing therapy group to launch in Whitehaven - Cumbria Crack

New climbing therapy group to launch in Whitehaven Cumbria Crack

Published: Feb. 26, 2026, 9:24 a.m.
Endometrial cancer, Campagnoli (GSK): "Immunotherapy increases overall survival." - lamilano.it

Endometrial cancer, Campagnoli (GSK): "Immunotherapy increases overall survival." lamilano.it

Published: Feb. 23, 2026, 5:15 p.m.
Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." - lamilano.it

Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." lamilano.it

Published: Feb. 23, 2026, 5:12 p.m.
Adjustable Continence Therapy data for SUI, with Sasha Vereecken - Contemporary OB/GYN

Adjustable Continence Therapy data for SUI, with Sasha Vereecken Contemporary OB/GYN

Published: Feb. 23, 2026, 3:52 p.m.
Endometrial cancer: AIFA approves immunotherapy with chemotherapy for all patients. - lamilano.it

Endometrial cancer: AIFA approves immunotherapy with chemotherapy for all patients. lamilano.it

Published: Feb. 23, 2026, 1:30 p.m.
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer - CancerNetwork

Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer CancerNetwork

Published: Feb. 21, 2026, 2:18 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!